US Stock Market Move | Boston Scientific Corporation (BSX.US) plunges over 15% as its performance guidance for the fiscal year 2026 falls below expectations.

date
23:58 04/02/2026
avatar
GMT Eight
On Wednesday, Boston Scientific (BSX.US) plummeted over 15%, marking the largest intraday drop since March 2020, now trading at $77.80.
On Wednesday, Boston Scientific Corporation (BSX.US) fell over 15%, marking its largest intraday decline since March 2020, now trading at $77.80. On the news front, the company's guidance for the fiscal year 2026 shows an adjusted earnings per share expectation of $3.43-3.49, slightly lower than the analysts' average expectation of $3.47. The full-year revenue is expected to be between $22.181 billion and $22.383 billion, lower than analysts' average expectation of $22.368 billion.